Metabolic Syndrome Criteria (IDF 2006)
IDF 2006 criteria for metabolic syndrome. Central obesity is required plus ≥2 of 4 additional criteria.
Score interpretation
The IDF definition requires central obesity. (The 2009 harmonised definition counts any 3 of the 5 criteria — check the others if waist is below the cut-off.)
→ Maintain healthy weight; lifestyle counselling; treat any individual risk factor present.
Central obesity present but fewer than 2 additional criteria.
→ Weight-loss target 5–10%; lifestyle modification; recheck lipids, BP and glucose annually.
Central obesity + ≥ 2 additional criteria.
→ Cardiovascular risk assessment; lifestyle intervention; treat individual components; consider referral.
Interpretation bands for the Metabolic Syndrome. Apply clinical judgement and local guidance.
References
- Alberti KG, et al. The metabolic syndrome — a new worldwide definition. Lancet. 2005;366(9491):1059-1062.
- Alberti KG et al. Harmonizing the metabolic syndrome. Circulation 2009;120:1640-1645.
Related
Curated clinical cross-links plus same-class fallbacks.
- Ziprasidone · Atypical Antipsychotic — D2/5-HT2A Antagonist (Low Metabolic Risk)
- Atorvastatin (CKD Cardiovascular Risk) · Cardiovascular Risk in CKD
- Icosapent Ethyl (Omega-3 — Cardiovascular Risk Reduction) · Omega-3 Fatty Acid (Purified EPA — Eicosapentaenoic Acid Ethyl Ester)
- Insulin (IV Infusion — ICU Glucose Control) · Insulin — ICU Glucose Management
- Trimetazidine · Metabolic Anti-Anginal
- L-Carnitine · Antidote / Metabolic Agent
- Diabetic Ketoacidosis (DKA) · JBDS 2013 / Joint British Diabetes Societies; NICE NG17
- Adult Hypoglycaemia (Treated Diabetes) · JBDS-IP (2023): Hospital Management of Hypoglycaemia
- Adrenal Crisis · Society for Endocrinology Emergency Guidance (2024)
- Type 2 Diabetes Management · NICE NG28 2022
- Hyperthyroidism Management · BTA / ETA 2018
- Adrenal Insufficiency · Society of Endocrinology / ESE 2016
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.